healthcareЗдравоохранение. HealthcareHealthcare1027-7218Republican Scientific and Practical Center for Medical Technologies, Informatization, Management and Health Economics10.65249/1027-7218-2025-12-4-14healthcare-227Research ArticleОБЩЕСТВЕННОЕ ЗДОРОВЬЕ И ЗДРАВООХРАНЕНИЕPUBLIC HEALTH AND HEALTHCAREОценка риска сердечно-сосудистых заболеваний в общей популяции: обоснование выбора модели прогнозирования с учетом возрастаCardiovascular disease risk assessment in the general population: rationale for selection of prognostic model regarding agehttps://orcid.org/0000-0002-8213-2968ШепелькевичА. П.ShepelkevichA.

Шепелькевич Алла Петровна – д. м. н., профессор кафедры эндокринологии, председатель Белорусского общественного медицинского объединения «Эндокринология и метаболизм»

Пр. Дзержинского, 83, 220007, г. Минск

https://orcid.org/0009-0001-1976-7426БаалбакиД. Д.BaalbakiD.

Баалбаки Диана Джамал

Пр. Дзержинского, 83, 220007, г. Минск

ПристромА. М.PristromA.

Пр. Дзержинского, 83, 220007, г. Минск

https://orcid.org/0000-0002-6836-3794ЮреняЕ. В.YureniaA.

Юреня Елена Васильевна

Пр. Дзержинского, 83, 220007, г. Минск

Белорусский государственный медицинский университетBelarusРеспубликанский научно-практический центр «Кардиология»BelarusМинский городской клинический эндокринологический центрBelarus202517012026012414Copyright © Шепелькевич А.П., Баалбаки Д.Д., Пристром А.М., Юреня Е.В., 20262026Шепелькевич А.П., Баалбаки Д.Д., Пристром А.М., Юреня Е.В.Shepelkevich A., Baalbaki D., Pristrom A., Yurenia A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://healthcare.ejournal.by/jour/article/view/227

Проведен анализ шкал для оценки общего кардиоваскулярного риска в общей популяции. В настоящее время существует большое количество моделей прогнозирования для оценки кардиоваскулярного риска, преимущественно в среднем и пожилом возрасте. С учетом современных рекомендаций для оценки общего кардиоваскулярного риска в общей популяции оптимально использовать шкалы SCORE2 и SCORE2-ОР, для пациентов с сахарным диабетом 2-го типа – SCORE2-Diabetes. Прогнозирование кардиоваскулярного риска у лиц молодого возраста является сложной задачей, так как большинство шкал ограничены возрастом 40 лет. На сегодняшний день для оценки 10-летнего общего кардиоваскулярного риска у лиц моложе 40 лет предложены следующие модели: модифицированная шкала Framingham 2008 (с 30 лет) и QRISK3 (с 25 лет), не валидированные в Республике Беларусь. Проведение валидации шкал для оценки кардиоваскулярного риска у лиц молодого возраста в конкретной популяции является важной научной и практической задачей в условиях роста заболеваемости сердечно-сосудистых заболеваний у данной категории пациентов.

This article conducts an analysis of risk scores for total cardiovascular risk assessment in the general population. Currently, a plethora of prognostic models for evaluating cardiovascular risk are available, especially for middle-aged and elderly individuals. Considering the latest recommendations, it is optimal to use SCORE2 and SCORE2-OP risk scores for total cardiovascular risk assessment in the general population and SCORE2-Diabetes – for patients with type 2 diabetes. Predicting cardiovascular risk in young individuals is a challenging task, as most risk scores are limited to those aged 40 and above. To date, for the estimation of total 10-year cardiovascular risk in individuals under 40, the following risk scores could be used: the modified Framingham scale 2008 (from age 30) and QRISK3 (from age 25) which are not yet validated in the Republic of Belarus. Conducting validation of risk score for cardiovascular risk assessment in young individuals is an important scientific and clinical task considering the excess cardiovascular morbidity within this demographic.

сердечно-сосудистые заболеваниякардиоваскулярный рискшкалы оценки рискапрогностические моделивалидацияcardiovascular diseasescardiovascular riskrisk scoresprognostic modelsvalidationReferencesCardiovascular diseases. – World Health Organization. – URL: https://www.who.int/ru/health-topics/cardiovasculardiseases#tab=tab_1 (date of access: 10.08.2025).World Health Organization. Cardiovascular diseases. Available at: https://www.who.int/ru/health-topics/cardiovasculardiseases#tab=tab_1 (accessed: 10.08.2025)World Heart Report 2023: confronting the world’s number one killer / M. Di Cesare, H. Bixby, T. Gaziano [et al.]. – Geneva (Switzerland) : World Heart Federation, 2023.Cesare M.Di, Bixby H., Gaziano T., et al. World Heart Report 2023: Confronting the world’s number one killer. World Heart Federation. 2023.Global burden of cardiovascular diseases: projections from 2025 to 2050 / B. Chong, J. Jayabaskaran, S.M. Jauhari [et al.] // European Journal of Preventive Cardiology. – 2024. – Vol. 32, № 11. – doi: 10.1093/eurjpc/zwae281.Chong B., Jayabaskaran J., Jauhari S.M., et al. Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur J Preventive Cardiol. 2024. doi: 10.1093/eurjpc/zwae281.Global burden of cardiovascular diseases and risks collaboration, 1990–2021 / M. Lindstrom, N. DeCleene, H. Dorsey [et al.] // Journal of the American College of Cardiology. – 2022. – Vol. 80. – doi: 10.1016/j.jacc.2022.11.001.Lindstrom M., DeCleene N., Dorsey H., et al. Global burden of cardiovascular diseases and risks collaboration, 1990–2021. J Am Coll Cardiol. 2022; 80. doi: 10.1016/j.jacc.2022.11.001.Clinical determinants of ischemic heart disease in Eastern Europe / E. Cenko, O. Manfrini, N. Fabin [et al.] // Lancet Regional Health – Europe. – 2023. – Vol. 33. – doi: 10.1016/j.lanepe.2023.100698.Cenko E., Manfrini O., Fabin N., et al. Clinical determinants of ischemic heart disease in Eastern Europe. The Lancet Regional Health – Europe. 2023; 33. doi: 10.1016/j.lanepe.2023.100698.European mortality database. – European health information gateway. – URL: https://gateway.euro.who.int/en/datasets/european-mortality-database/ (date of access: 19.07.2025).European health information gateway. European mortality database. World Health Organization. Available at: https://gateway.euro.who.int/en/datasets/european-mortality-database/ (accessed: 19.07.2025)Hajar, R. Framingham Contribution to Cardiovascular Disease / R. Hajar // Heart Views. – 2016. – Vol. 17, № 2. – P. 78–81.Hajar R. Framingham contribution to cardiovascular disease. Heart Views. 2016; 17(2): 78–81.Распространенность факторов риска неинфекционных заболеваний в Республике Беларусь, 2020. – Всемирная организация здравоохранения: Европейский регион, 2020. – 89 с. – URL: https://cdn.who.int/media/docs/default-source/ncds/ncdsurveillance/data-reporting/belarus/belarus_steps_report_2020_ru.pdf (дата обращения:10.09.2025).Prevalence of risk factors for non-communicable diseases in the Republic of Belarus STEPS 2020. Vsemirnaya organizaciya zdravoohraneniya : Evropejskij region. 2020. 89. Available at: https://cdn.who.int/media/docs/default-source/ncds/ncd-surveillance/data-reporting/belarus/belarus_steps_report_2020_ru.pdf (accessed: 10.09.2025) (in Russian)IDF Diabetes Atlas. – 11th edn. – Brussels : International Diabetes Federation, 2025. – URL: https://diabetesatlas.org/media/uploads/sites/3/2025/04/IDF_Atlas_11th_Edition_2025.pdf (date of access:15.08.2025).IDF Diabetes Atlas. Brussels. 2025. Available at: https://diabetesatlas.org/media/uploads/sites/3/2025/04/IDF_Atlas_11th_Edition_2025.pdf (accessed: 10.09.2025).Global Health Estimates. – World Health Organization, 2023. –URL: https://www.who.int/data/global-health-estimates (date of access: 01.09.2025).Global Health Estimates. WHO. 2023. Available at: https://www.who.int/data/global-health-estimates (accessed: 01.09.2025).Diabetes mortality: trends and multi-country analysis of the Americas from 2000 to 2019 / C. Antini, R. Caixeta, S. Luciani, A. Hennis // International Journal of Epidemiology. – 2024. – Vol. 53, № 1. – doi: 10.1093/ije/dyad182.Antini C., Caixeta R., Luciani S., Hennis A. Diabetes mortality: trends and multi-country analysis of the Americas from 2000 to 2019. Int J Epidemiol. 2024; 53(1). doi: 10.1093/ije/dyad182.Современное состояние эндокринологической службы Республики Беларусь / О. Б. Салко, А. В. Солнцева, А. П. Шепелькевич [и др.] // Рецепт. – 2023. – Т. 26, № 5. – С. 515–533.Salko O.B., Solntseva A.V., Shepel'kevich A.P., et al. Current state of endocrinology service of the Republic of Belarus. Retsept. 2023; 26(5): 515–533. (in Russian)Mortality and causes of death in the WHO multinational study of vascular disease in diabetes / N. J. Morrish, S. L. Wang, L. K. Stevens [et al.] // Diabetologia. – 2001. – Vol. 44. – P. 14–21.Morrish N.J., Wang S.L., Stevens L.K., et al. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001; 44: 14–21.Rose, G. Sick individuals and sick populations / G. Rose // International Journal of Epidemiology. – 1985. – Vol. 14, № 1. – P. 32–38.Rose G. Sick individuals and sick populations. Int J Epidemiol. 1985; 14(1): 32–38.The North Karelia project: from North Karelia to national action / ed.: P. Puska, E. Vartiainen, T. Laatikainen [et al.] // The National Institute for Health and Welfare (THL). – Helsinki : Helsinki University Printing House, 2009. – 309 р. – URL: https://www.julkari.fi/bitstream/handle/10024/80109/731beafd-b544-42b2-b853-baa87db6a046.pdf. (date of access: 01.09.2025).Puska P., Vartiainen E., Laatikainen T., et al. The North Karelia project: from North Karelia to national action. The National Institute for Health and Welfare (THL). Helsinki. 2009; 309. Available at: https://www.julkari.fi/bitstream/handle/10024/80109/731beafd-b544-42b2-b853-baa87db6a046.pdf. (accessed: 01.09.2025).Promoting cardiovascular health in the developing world: a critical challenge to achieve global health / Institute of Medicine (US) Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries; ed.: V. Fuster, B. B. Kelly // Washington (DC) : National Academies Press (US), 2010. – doi: 10.17226/12815.Fuster V., Kelly B.B (ed.). Promoting cardiovascular health in the developing world: a critical challenge to achieve global health. Institute of Medicine (US) Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries. Washington (DC). 2010; 5. doi: 10.17226/12815.2021 ESC Guidelines on cardiovascular disease prevention in clinical practice / L. F. Visseren, F. Mach, Y. M. Smulders [et al.] // European Heart Journal. – 2021. – Vol. 42, № 34. – doi: 10.1093/eurheartj/ehab484.Visseren L.F., Mach F., Smulders Y.M., et al. ESC Scientific Document Group, 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34). doi: 10.1093/eurheartj/ehab484.2019 ACC/AHA guideline on the primary prevention of cardiovascular disease : a report of the American college of cardiology/ American heart association task force on clinical practice guidelines ; D. K. Arnett, R. S. Blumenthal, M. A. Albert [et al.] // Circulation. – 2019. – Vol. 140, № 11. – doi: 10.1161/CIR.0000000000000725.Arnett D.K., Blumenthal R.S., Albert M.A., et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation. 2019; 140(11): doi: 10.1161/CIR.0000000000000725.Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection / K. R. Van Daalen, D. Zhang, S. Kaptoge [et al.] // The Lancet Global Health. – 2024. – Vol. 12, № 8. – doi: 10.1016/S2214-109X(24)00210-9.Van Daalen K.R., Zhang D., Kaptoge S., et al. Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection. The Lancet Global Health. 2024; 12(8). doi: 10.1016/S2214-109X(24)00210-9.Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence / G. S. Collins, P. Dhiman, C. L. Andaur Navarro[et al.] // BMJ Open. – 2021. – Vol. 11. – doi: 10.1136/bmjopen-2020-048008.Collins G.S., Dhiman P., Andaur Navarro C.L., et al. Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence. BMJ Open. 2021; 11. doi: 10.1136/bmjopen-2020-048008.Национальные рекомендации по профилактике сердечно-сосудистых заболеваний в клинической практике / М-во здравоохранения Респ. Беларусь, Респ. науч-практ. центр «Кардиология», Белор. науч. о-во кардиологов. – Мн. : ДокторДизайн. – 2010. – 20 с.National guidelines for the prevalence of cardiovascular diseases in clinical practice. Minsk. 2010; 20. (in Russian)О порядке проведения диспансеризации взрослого населения : постановление Министерства здравоохранения Республики Беларусь от 16.12.2024 №173 // Национальный правовой Интернет-портал Республики Беларусь. – URL: https://pravo.by/t/?guid=12551&p0=W22442590 (дата обращения: 25.08.2025).O poryadke provedeniya dispanserizacii vzroslogo naseleniya. postanovlenie Ministerstva zdravookhraneniya Respubliki Belarus' 16.12.2024 №173. Available at: https://pravo.by/document/?guid=12551&p0=W22442590 (accessed: 01.09.2025). (in Russian)Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project / R. M. Conroy, K. Pyorala, A. Fitzgerald [et al.] // European Heart Journal. – 2003. – Vol. 24. – P. 987–1003.Conroy R.M., Pyorala K., Fitzgerald A., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24: 987–1003.SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe / SCORE2 working group and ESC Cardiovascular risk collaboration // European Heart Journal. – 2021. – Vol. 42. –doi: 10.1093/eurheartj/ehab309.SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021; 42. doi: 10.1093/eurheartj/ehab309.SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions / SCORE-OP working group and ESC cardiovascular risk collaboration // European Heart Journal. – 2021. – Vol. 42. – doi: 10.1093/eurheartj/ehab312.SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021; 42. doi: 10.1093/eurheartj/ehab312.World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions / WHO CVD Risk Chart Working Group // Lancet Global Health. – 2019. – Vol. 7. – doi: 10.1016/S2214-109X(19)30318-3.World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health. 2019; 7. doi: 10.1016/S2214-109X(19)30318-3.A novel risk score to predict cardiovascular disease risk in national populations (Globorisk) : a pooled analysis of prospective cohorts and health examination surveys / K. Hajifathalian, P. Ueda, Y. Lu [et al.] // Lancet Diabetes Endocrinology. – 2015. – Vol. 3. – doi: 10.1016/S2213-8587(15)00081-9.Hajifathalian K., Ueda P., Lu Y., et al. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk). Lancet Diabetes Endocrinol. 2015; 3: 339–355. doi: 10.1016/S2213-8587(15)00081-9.Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART modifiable risk score / C. McGorrian, S. Yusuf, S. Islam [et al.] // European Heart Journal. – 2011. – Vol. 32. – P. 581–589.McGorrian C., Yusuf S., Islam S., et al. Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART modifiable risk score. Eur Heart J. 2011; 32: 581–589.Eisen, A. Updates on acute coronary syndrome: a review / A. Eisen, R. P. Giugliano, E. Braunwald // JAMA Cardiology. – 2016. – Vol. 1. – P.718–730.Eisen A., Giugliano R.P., Braunwald E. Updates on acute coronary syndrome: a review. JAMA Cardiol. 2016; 1: 718–730.Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010 / A. Gupta, Y. Wang, J. A. Spertus [et al.] // Journal of the American College of Cardiology. – 2014. – Vol. 64. – P. 337–345.Gupta A., Wang Y., Spertus J.A., et al. Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010. J Am Coll Cardiol. 2014; 64: 337–345. doi: 10.1016/j.jacc.2014.04.054.Challenges and opportunities for the prevention and treatment of cardiovascular disease among young adults : report from a national heart, lung, and blood institute working group / H. C. Gooding, S. S. Gidding, A. E. Moran [et al.] // Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease. – 2020. – Vol. 9, № 19. – doi: 10.1161/JAHA.120.016115.Gooding H.C., Gidding S.S., Moran A.E., et al. Challenges and opportunities for the prevention and treatment of cardiovascular disease among young adults. J Am Hear Assoc Cardiovasc Cerebrovasc Dis. 2020; 9(19). doi: 10.1161/JAHA.120.016115.Twenty-year trends and sex differences in young adults hospitalized with acute myocardial infarction / S. Arora, G.A. Stouffer, A.M. Kucharska-Newton [et al.] // Circulation – 2019. – Vol. 139. – P. 1047–1056.Arora S., Stouffer G.A., Kucharska-Newton A.M., et al. Twenty-year trends and sex differences in young adults hospitalized with acute myocardial infarction. Circulation. 2019; 139: 1047–1056.Sex differences in young patients with acute myocardial infarction : a VIRGO study analysis / E. M. Bucholz, K. M. Strait, R. P. Dreyer [et al.] // European Heart Journal – Acute CardioVascular Care. – 2017. – Vol. 6. – P. 610–622.Bucholz E.M., Strait K.M., Dreyer R.P., et al. Sex differences in young patients with acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2017; 6: 610–622.Cardiovascular risk and statin eligibility of young adults after an MI : partners YOUNG-MI registry / A. Singh, B.L.Collins, A. Gupta [et al.] // Journal of the American College of Cardiology. – 2018. – Vol. 71, №3. – P. 292–302.Singh A., Collins B.L., Gupta A., et al. Cardiovascular risk and statin eligibility of young adults after an MI. J Am Coll Cardiol. 2018; 71(3): 292–302.General cardiovascular risk profile for use in primary care : the Framingham heart study / R. B. D'Agostino, R. S. Vasan, M. J. Pencina [et al.] // Circulation. – 2008. – Vol. 117, № 6. – P. 743–753.D'Agostino R.B., Vasan R.S., Pencina M.J., et al. General cardiovascular risk profile for use in primary care. Circulation. 2008; 117(6): 743–753.The Framingham prediction rule is not valid in a European population of treated hypertensive patients / S. Bastuji-Garin, A. Deverly, D. Moyse [et al.] // Journal of Hypertension. – 2002. – Vol. 20, №10. – P. 1973–1980.Bastuji-Garin S., Deverly A., Moyse D., et al. The Framingham prediction rule is not valid in a European population of treated hypertensive patients. J Hypertension. 2002; 20(10): 1973–1980.Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study / J. P. Empana, P. Ducimetière, D. Arveiler [et al.] // European Heart Journal. – 2003. – Vol. 24, № 21. – P. 1903–1911.Empana J.P., Ducimetiere P., Arveiler D., et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J. 2003; 24(21): 1903–1911.Hippisley-Cox, J. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study / J. Hippisley-Cox, C. Coupland, P. Brindle // BMJ. – 2017. – Vol. 357. – doi: 10.1136/bmj.j2099.Hippisley-Cox J., Coupland C., Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease. BMJ. 2017; 357. doi: 10.1136/bmj.j2099.

The authors declare that there are no conflicts of interest present.